CAS: 162640-98-4 - AT-56
![Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-](https://static.cymitquimica.com/products/IN/thumb/DA001TA4.jpg)
Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-
CAS:162640-98-4
Formula:
C25H27N5
Purity:
%
Color and Shape:
Solid
Molecular weight:
397.5154
Ref: IN-DA001TA4
| 25mg | 111.00 € | ||
| 50mg | 164.00 € | ||
| 100mg | 324.00 € |
Estimated delivery in United States, on Thursday 13 Feb 2025
AT-56
CAS:162640-98-4
AT56, a specific inhibitor of prostaglandin D2 synthase enzymatic activity, blunted adipogenic aldosterone effects.
Formula:
C25H27N5
Purity:
98.16% - 99.5%
Color and Shape:
Solid
Molecular weight:
397.52
Ref: TM-T1866
| 1mg | 39.00 € | ||
| 5mg | 82.00 € | ||
| 10mg | 123.00 € | ||
| 25mg | 235.00 € | ||
| 50mg | 423.00 € | ||
| 100mg | 625.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Thursday 20 Feb 2025
AT-56
Controlled ProductCAS:162640-98-4
Applications AT-56 is an orally active inhibitor of Lipocalin-type prostaglandin D synthase. References Irikura, D. …
Formula:
C25H27N5
Color and Shape:
Neat
Molecular weight:
397.515
Ref: TR-A786980
| 100mg | 2,353.00 € |
Estimated delivery in United States, on Wednesday 26 Mar 2025
AT-56
CAS:162640-98-4
AT-56 is a novel and well-tolerated drug that is used for the treatment of cancer. …
Formula:
C25H27N5
Purity:
Min. 95%
Molecular weight:
397.52 g/mol
Ref: 3D-MGA64098
| 25mg | 934.00 € | ||
| 50mg | 1,406.00 € | ||
| 100mg | 1,955.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
